CAS: 201349-37-3

Enisamium iodide is an antiviral agent synthesized from isonicotinic acid derivatives, which is a small molecule inhibitor of viral RNA polymerase. It interferes with the replication process of various viruses by inhibiting the activity of RNA-dependent RNA polymerase, crucial for viral genome synthesis. Enisamium iodide exhibits its antiviral properties by impeding the replication of single-stranded RNA viruses, thereby mitigating viral propagation in host cells. The primary application of enisamium iodide lies in its potential therapeutic use for treating viral infections, particularly those caused by influenza viruses. Its ability to target a fundamental component of the viral replication machinery renders it a promising candidate for addressing emerging viral threats. The compound's mechanism highlights its specificity and effectiveness, providing a foundation for further research and clinical trials aiming to validate its efficacy and safety profiles in combating viral diseases.

Enisamium iodide is used as an antiviral agent.